Clinical Trial Update: An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva. [Phase 3]

View source ↗

Summary

Phase 3 trial of palovarotene for fibrodysplasia ossificans progressiva has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrodysplasia Ossificans Progressiva

Drugs mentioned

• Palovarotene (palovarotene)

Snippet

Sponsor: Clementia Pharmaceuticals Inc. | Conditions: Fibrodysplasia Ossificans Progressiva | Phase 3 | Status: COMPLETED | Results posted: 2023-03-14